These Regulations may be cited as the Blood Safety and Quality (Amendment) (EU Exit) Regulations 2020 and come into force immediately before IP completion day.
資料由法律人 LawPlayer整理提供·UK legislation / curated by LawPlayer from legislation.gov.uk
The Blood Safety and Quality (Amendment) (EU Exit) Regulations 2020
The Blood Safety and Quality (Amendment) (EU Exit) Regulations 2019 are amended as follows.
For regulation 3 substitute—
(3) In regulation 1, in paragraph (3)—
(a) after the definition of “qualified health professional” insert —
“quality system” means the organisational structure, responsibilities, procedures, processes, and resources for implementing quality management and, for this purpose, “quality management” means the co-ordinated activities to direct and control an organisation with regard to quality at all levels within the blood establishment or hospital blood bank;
(b) for the definition of “third country”, substitute—
“third country” means—
in relation to the import of blood or blood components into Great Britain, a country other than the United Kingdom; and
in relation to the import of blood or blood components into Northern Ireland, a country other than Northern Ireland or a member State;
In regulation 4—
(a) in regulation 1A as inserted by regulation 4, in paragraph (1), after “these Regulations” insert “as they apply in relation to Great Britain”;
(b) in regulation 1B as inserted by regulation 4, after “and 13” insert “, as they apply in relation to Great Britain,”.
For regulation 5 substitute—
(5) In regulation 2—
(a) for the heading substitute “Designation of the competent authority for Northern Ireland and scope of the Regulations”;
(b) for paragraph (1) substitute—
(1) The Secretary of State is designated the competent authority in relation to Northern Ireland for the purposes of the Directive.
In regulation 6, for the inserted text substitute—
—
(i) in relation to Great Britain, in one or more establishments authorised under regulation 4, or in a country where the safety and quality standards for establishments authorised in that country are equivalent to those for establishments authorised under regulation 4, to undertake activities relating to the collection or testing (or both) of blood and blood components, or to their preparation, storage or distribution;
(ii) in relation to Northern Ireland, in one or more establishments authorised in a member State, or under regulation 4, to undertake such activities.
In regulation 7—
(a) for paragraph (a) substitute—
(a) for paragraph (1)(b) substitute—
(b) establish and maintain a quality system for blood establishments—
(i) in relation to Great Britain, that is based on the principles of good practice, which meets the standards and requirements set out in the Annex to Commission Directive 2005/62/EC and which gives effect to the Good Practice Guidelines for Blood Establishments Required to Comply with Directive 2005/62/EC published in the 20th edition of the Guide to the preparation, use and quality assurance of blood components ;
(ii) in relation to Northern Ireland, that is based on the principles of good practice, which complies with the Community standards and requirements set out in the Annex to Commission Directive 2005/62/EC and which gives effect to the requirements in respect of the use of good practice guidelines set out in Article 2.2 of that Directive;
(b) in paragraph (1A) inserted by paragraph (b), for the words “For the purposes of” substitute “In relation to Great Britain, for the purposes of”.
In regulation 9—
(a) for paragraph (a) substitute—
(a) for paragraph (1)(b) substitute—
(b) establish and maintain a quality system for the hospital blood bank—
(i) in relation to Great Britain, that is based on the principles of good practice, which meets the standards and requirements set out in the Annex to Commission Directive 2005/62/EC and which gives effect to the Good Practice Guidelines for Blood Establishments Required to Comply with Directive 2005/62/EC published in the 20th edition of the Guide to the preparation, use and quality assurance of blood components;
(ii) in relation to Northern Ireland, that is based on the principles of good practice, which complies with the Community standards and requirements set out in the Annex to Commission Directive 2005/62/EC and which gives effect to the requirements in respect of the use of good practice guidelines set out in Article 2.2 of that Directive;
(b) in paragraph (1A) inserted by paragraph (b), for the words “For the purposes of” substitute “In relation to Great Britain, for the purposes of”.
In regulation 10, for paragraph (a) substitute—
(a) in the heading, for “the United Kingdom” substitute “Great Britain”;
(aa) for the opening words substitute—
Any person who imports blood or blood components into Great Britain from a third country must ensure that each unit which they import—
After regulation 10, insert—
(10A) After regulation 13 insert—
Import of blood and blood components into Northern Ireland
(13A) Any person who imports blood or blood components into Northern Ireland from a third country must ensure that each unit which they import—
(a) has been prepared in accordance with standards equivalent to the standards and requirements set out in the Annex to Commission Directive 2005/62/EC ; and
(b) meets standards of quality and safety equivalent to those laid down in Part 5 of the Schedule.
For regulation 11, substitute—
(11) For regulation 16A substitute—
Requirement that the Secretary of State communicate certain information in respect of Northern Ireland to other competent authorities
(16A) The Secretary of State must, in respect of Northern Ireland, communicate to the competent authorities of member States such information as is appropriate with regard to serious adverse reactions and events in order to guarantee that blood or blood components known or suspected to be defective are withdrawn from use and discarded.
For regulation 12 substitute—
(12)
(1) In regulation 23—
(a) at the end of the heading insert “in relation to Great Britain”;
(b) in paragraph (1), for the words from “he shall” to the end of that paragraph substitute “the Secretary of State must, in relation to Great Britain, notify blood establishments that those criteria must be adopted.”.
(2) After regulation 23 insert—
Specific epidemiological situations in relation to Northern Ireland
(23ZA)
(1) Where the Secretary of State is aware of a specific epidemiological situation, such as an outbreak of a disease, which may affect the safety of blood donations, and as a result of which the Secretary of State considers that specific deferral criteria for the collection of blood donations should be adopted, the Secretary of State must in relation to Northern Ireland—
(a) notify blood establishments that those criteria must be adopted; and
(b) notify the Commission of—
(i) the epidemiological situation; and
(ii) the additional deferral criteria which blood establishments are required to adopt in relation to it pursuant to sub-paragraph (a).
(2) A blood establishment shall adopt and comply with any criteria for additional tests notified to them by the Secretary of State pursuant to paragraph (1).
In regulation 13—
(a) for the opening words substitute “After regulation 23ZA, as inserted by regulation 12(2), insert”;
(b) in regulation 23A as inserted by regulation 13—
(i) in paragraph (1), for the opening words substitute “An appropriate authority in Great Britain may by regulations make provision in relation to—”;
(ii) for paragraph (1)(a) substitute—
(a) standards and requirements relating to a quality system for blood establishments and hospital blood banks, including provision amending regulations 7(1)(b), 9(1)(b) and 13(a) in so far as those provisions relate to those standards and requirements;
(iii) in paragraph (1)(e), for “regulation 7(3)(b)” substitute “regulations 7(3)(b), 9(1)(h)”;
(iv) in paragraph (1)(g), for “regulation 8” substitute “regulations 8, 9(1)(e)”;
(v) omit paragraph (3)(d);
(vi) for paragraph (3)(e) substitute—
(e) in relation to the whole of Great Britain, the Secretary of State acting with the consent of the Welsh Ministers and the Scottish Ministers
(c) in regulation 23B as inserted by regulation 13, omit paragraph (3);
(d) omit regulation 23F as inserted by regulation 13.
For regulation 14 substitute—
(14) In Part 3 of the Schedule, in paragraph 1, for the sentence beginning with “All such cases” substitute—
All such cases must be clearly documented and subject to—
(a) in relation to Great Britain, the requirements in regulation 7;
(b) in relation to Northern Ireland, the quality management provisions in Articles 11, 12, and 13 of Directive 2002/98/EC .
Cite this legislation
The Blood Safety and Quality (Amendment) (EU Exit) Regulations 2020 (legislation.gov.uk, OGL v3.0). Retrieved via LawPlayer, https://lawplayer.com/uk/act/uksi-2020-1304 (accessed 2026-07-06)
Contains public sector information licensed under the Open Government Licence v3.0.
本頁資料來源:legislation.gov.uk (The National Archives)·整理提供:法律人 LawPlayer· lawplayer.com